1. Choi WS, Noh JY, Huh JY, Jo YM, Lee J, Song JY, et al. Disease burden of herpes zoster in Korea. J Clin Virol. 2010; 47:325–329. PMID:
20181512.
Article
2. Jung HS, Kang JK, Yoo SH. Epidemiological study on the incidence of herpes zoster in the nearby Cheonan. Korean J Pain. 2015; 28:193–197.
Article
3. Nahm FS, Kim SH, Kim HS, Shin JW, Yoo SH, Yoon MH, et al. Survey on the treatment of postherpetic neuralgia in Korea; multicenter study of 1,414 patients. Korean J Pain. 2013; 26:21–26. PMID:
23342203.
Article
4. Opstelten W, Zuithoff NP, van Essen GA, van Loon AM, van Wijck AJ, Kalkman CJ, et al. Predicting postherpetic neuralgia in elderly primary care patients with herpes zoster: prospective prognostic study. Pain. 2007; 132(Suppl 1):S52–S59. PMID:
17379412.
Article
5. Jung BF, Johnson RW, Griffin DR, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology. 2004; 62:1545–1551. PMID:
15136679.
Article
6. Zaal MJ, Volker-Dieben HJ, D'Amaro J. Risk and prognostic factors of postherpetic neuralgia and focal sensory denervation: a prospective evaluation in acute herpes zoster ophthalmicus. Clin J Pain. 2000; 16:345–351. PMID:
11153792.
Article
7. Pica F, Gatti A, Divizia M, Lazzari M, Ciotti M, Sabato AF, et al. One-year follow-up of patients with long-lasting post-herpetic neuralgia. BMC Infect Dis. 2014; 14:556. PMID:
25361823.
Article
8. Hillebrand K, Bricout H, Schulze-Rath R, Schink T, Garbe E. Incidence of herpes zoster and its complications in Germany, 2005-2009. J Infect. 2015; 70:178–186. PMID:
25230396.
Article
9. Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, et al. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007; 44(Suppl 1):S1–S26. PMID:
17143845.
Article
10. Jeon Y. Herpes zoster and postherpetic neuralgia: practical consideration for prevention and treatment. Korean J Pain. 2015; 28:177–184.
Article
11. Wood MJ, Kay R, Dworkin RH, Soong SJ, Whitley RJ. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis. 1996; 22:341–347. PMID:
8838194.
Article
12. Jackson JL, Gibbons R, Meyer G, Inouye L. The effect of treating herpes zoster with oral acyclovir in preventing post-herpetic neuralgia. A meta-analysis. Arch Intern Med. 1997; 157:909–912. PMID:
9129551.
Article
13. Kumar V, Krone K, Mathieu A. Neuraxial and sympathetic blocks in herpes zoster and postherpetic neuralgia: an appraisal of current evidence. Reg Anesth Pain Med. 2004; 29:454–461. PMID:
15372391.
Article
14. Kim KH. Herpes zoster vaccination. Korean J Pain. 2013; 26:242–248. PMID:
23861997.
Article
15. Schmader KE, Levin MJ, Gnann JW Jr, McNeil SA, Vesikari T, Betts RF, et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis. 2012; 54:922–928. PMID:
22291101.
Article
16. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005; 352:2271–2284. PMID:
15930418.
Article